Cleancard
London
About Cleancard
We are combining synthetic biology and artificial intelligence to make cancer screening as easy as a pregnancy test. Cleancard is bringing lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine in just 30 minutes. Our rapid at-home screens can identify prostate, bladder and ovarian cancers. We are constantly expanding the number of conditions we can detect from a single sample using our platform technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.0M
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2023)
- Website: cleancard.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cleancard-2484 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.